These results clarify the molecular mechanism by which the KLK1‐B1R axis inhibits inflammation‐cancer transformation by regulating fibroblast phenotypic transformation and ECM dynamic balance, providing a new strategy for targeted intervention. The gene discussed is KLK1; the disease is cancer.